Target intelligence / Profile preview

Sphingosine-1-Phosphate Pathway (S1P Pathway)

Target: S1P Pathway
Molecular classification: Lipid signaling pathway

Overview

The sphingosine-1-phosphate (S1P) pathway is a critical lipid signaling cascade involved in numerous physiological and pathological processes, including immune cell trafficking, vascular development, and inflammation. S1P is a bioactive sphingolipid metabolite produced by the phosphorylation of sphingosine via two isoenzymes: sphingosine kinase 1 (Sphk1) and sphingosine kinase 2 (Sphk2). It exerts its effects primarily through five G protein-coupled receptors (S1PR1–5).

Mechanism of action

Modulation of S1P receptors

Biological functions

Immune cell traffickingVascular developmentInflammationCell survivalActin remodeling

Disease associations

Autoimmune diseasesInflammatory diseasesCancer

Interacting drugs

Fingolimod

Beyond the preview

Go deeper on Sphingosine-1-Phosphate Pathway (S1P Pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sphingosine-1-Phosphate Pathway (S1P Pathway).

Explore the full profile